English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2358]
News [4933]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
Targeted drug shows activity against brain metastases in kidney cancer
Targeted drug shows activity against brain metastases in kidney cancer
More people with cancer undergoing radiotherapy prefer telemedicine to in-person visits
More people with cancer undergoing radiotherapy prefer telemedicine to in-person visits
Targeting cancer at the nanoscale
Targeting cancer at the nanoscale
Targeted prostate cancer screening could benefit men with inherited cancer syndrome
Targeted prostate cancer screening could benefit men with inherited cancer syndrome
Study identifies potential combination therapy for brain metastases of breast cancer
Study identifies potential combination therapy for brain metastases of breast cancer
Researchers use computer modelling to predict patient tumour responses to radiation therapy
Researchers use computer modelling to predict patient tumour responses to radiation therapy
High immunoscores may help some win the battle against cancer
High immunoscores may help some win the battle against cancer
Positive CHMP opinion recieved for amivantamab for the treatment of patients with advanced non-small cell lung cancer with EGFR exon 20 insertion mutations after failure of platinum-based therapy
Positive CHMP opinion recieved for amivantamab for the treatment of patients with advanced non-small cell lung...
FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer
FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer
Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer
Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer
<1...156157158159160...494>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top